IQVIA Holdings Inc. (IQV) Yield on Cost (YOC): N/A
The yield on cost (YOC) for IQVIA Holdings Inc. (IQV) is N/A.
IQV Yield on Cost (YOC) Metrics
YIELD ON COST (YOC)
N/A
Interactive Yield on Cost Calculator
Project custom investment returns for IQVIA Holdings Inc. (IQV) based on your custom cost basis.
Starting Yield
1.07%
Ending YOC
3.41%
Year 15 Dividend
$6.34
Cum. Dividends Recd.
$58.65
| Year | Projected Div. / Share | YoY Dividend Hike | Yield on Cost (YOC) | Total Dividends Recd. |
|---|---|---|---|---|
| Initial | $2.00 | — | 1.07% | $0.00 |
| Year 1 | $2.16 | +8.00% | 1.16% | $2.16 |
| Year 2 | $2.33 | +8.00% | 1.25% | $4.49 |
| Year 3 | $2.52 | +8.00% | 1.35% | $7.01 |
| Year 4 | $2.72 | +8.00% | 1.46% | $9.73 |
| Year 5 | $2.94 | +8.00% | 1.58% | $12.67 |
| Year 6 | $3.17 | +8.00% | 1.70% | $15.85 |
| Year 7 | $3.43 | +8.00% | 1.84% | $19.27 |
| Year 8 | $3.70 | +8.00% | 1.99% | $22.98 |
| Year 9 | $4.00 | +8.00% | 2.15% | $26.97 |
| Year 10 | $4.32 | +8.00% | 2.32% | $31.29 |
| Year 11 | $4.66 | +8.00% | 2.50% | $35.95 |
| Year 12 | $5.04 | +8.00% | 2.70% | $40.99 |
| Year 13 | $5.44 | +8.00% | 2.92% | $46.43 |
| Year 14 | $5.87 | +8.00% | 3.15% | $52.30 |
| Year 15 | $6.34 | +8.00% | 3.41% | $58.65 |
Yield on Cost (YOC) Formula
Formula: Yield on Cost = Annual Dividend / Original Purchase Price × 100
Inputs shown in the projection:
- Original purchase price.
- Annual dividend per share at the starting point.
- Assumed annual dividend growth rate.
- Projected annual dividend divided by original purchase price.
Note: Forward projections assume dividends continue to grow at the designated growth rate. Actual dividend payments are declared by corporate boards and are subject to change.
IQVIA Holdings Inc. Yield on Cost (YOC) Formula & Definition
Yield on Cost shows the dividend yield based on your original purchase price. As dividends grow, your YOC increases even if the market yield stays the same.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
About IQVIA Holdings Inc.
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Ari Bousbib